Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Pharmacodynamic Effects of Sulbactam/Meropenem/Polymyxin-B Combination Against Extremely Drug Resistant Acinetobacter baumannii Using Checkerboard Information.

Menegucci TC, Fedrigo NH, Lodi FG, Albiero J, Nishiyama SAB, Mazucheli J, Carrara-Marroni FE, Voelkner NMF, Gong H, Sy SKB, Tognim MCB.

Microb Drug Resist. 2019 Nov;25(9):1266-1274. doi: 10.1089/mdr.2018.0283. Epub 2019 Jun 19.

PMID:
31216222
2.

Reduced bioavailability of oral amoxicillin tablets compared to suspensions in Roux-en-Y gastric bypass bariatric subjects.

Montanha MC, Dos Santos Magon TF, de Souza Alcantara C, Simões CF, Silva SRB, Kuroda CM, Yamada SS, de Oliveira LES, Nasser D, Junior NN, Mazucheli J, Diniz A, Paixão PJPA, Kimura E.

Br J Clin Pharmacol. 2019 Sep;85(9):2118-2125. doi: 10.1111/bcp.14023. Epub 2019 Jul 12.

PMID:
31215676
3.

Pharmacodynamic Attainment of the Synergism of Meropenem and Fosfomycin Combination against Pseudomonas aeruginosa Producing Metallo-β-Lactamase.

Albiero J, Mazucheli J, Barros JPDR, Szczerepa MMDA, Nishiyama SAB, Carrara-Marroni FE, Sy S, Fidler M, Sy SKB, Tognim MCB.

Antimicrob Agents Chemother. 2019 May 24;63(6). pii: e00126-19. doi: 10.1128/AAC.00126-19. Print 2019 Jun.

4.

Mixture and nonmixture cure fraction models assuming discrete lifetimes: Application to a pelvic sarcoma dataset.

de Oliveira RP, Menezes AFB, Mazucheli J, Achcar JA.

Biom J. 2019 Jul;61(4):813-826. doi: 10.1002/bimj.201800030. Epub 2019 Feb 14.

PMID:
30762893
5.

Pharmacodynamic Evaluation of Fosfomycin against Escherichia coli and Klebsiella spp. from Urinary Tract Infections and the Influence of pH on Fosfomycin Activities.

Fedrigo NH, Mazucheli J, Albiero J, Shinohara DR, Lodi FG, Machado ACDS, Sy SKB, Tognim MCB.

Antimicrob Agents Chemother. 2017 Jul 25;61(8). pii: e02498-16. doi: 10.1128/AAC.02498-16. Print 2017 Aug.

6.

Pharmacodynamic Evaluation of the Potential Clinical Utility of Fosfomycin and Meropenem in Combination Therapy against KPC-2-Producing Klebsiella pneumoniae.

Albiero J, Sy SK, Mazucheli J, Caparroz-Assef SM, Costa BB, Alves JL, Gales AC, Tognim MC.

Antimicrob Agents Chemother. 2016 Jun 20;60(7):4128-39. doi: 10.1128/AAC.03099-15. Print 2016 Jul.

7.

Strategies for the treatment of polymyxin B-resistant Acinetobacter baumannii infections.

Menegucci TC, Albiero J, Migliorini LB, Alves JL, Viana GF, Mazucheli J, Carrara-Marroni FE, Cardoso CL, Tognim MC.

Int J Antimicrob Agents. 2016 May;47(5):380-5. doi: 10.1016/j.ijantimicag.2016.02.007.

PMID:
27068675
8.

The use of asymmetric distributions in average bioequivalence.

de Souza RM, Achcar JA, Martinez EZ, Mazucheli J.

Stat Med. 2016 Jul 10;35(15):2525-42. doi: 10.1002/sim.6885. Epub 2016 Feb 2.

PMID:
26840012
9.

The exponentiated exponential mixture and non-mixture cure rate model in the presence of covariates.

Mazucheli J, Coelho-Barros EA, Achcar JA.

Comput Methods Programs Biomed. 2013 Oct;112(1):114-24. doi: 10.1016/j.cmpb.2013.06.015. Epub 2013 Aug 9.

PMID:
23932336
10.

The Lindley distribution applied to competing risks lifetime data.

Mazucheli J, Achcar JA.

Comput Methods Programs Biomed. 2011 Nov;104(2):188-92. doi: 10.1016/j.cmpb.2011.03.006. Epub 2011 May 7.

PMID:
21550685
11.

How the lower face soft tissue changes after mandibular advancement or setback.

Alves PV, Mazucheli J, Vogel CJ, Bolognese AM.

J Craniofac Surg. 2008 May;19(3):593-8. doi: 10.1097/SCS.0b013e31816aaa79.

PMID:
18520370
12.

A protocol for cranial base reference in cephalometric studies.

Alves PV, Mazucheli J, Vogel CJ, Bolognese AM.

J Craniofac Surg. 2008 Jan;19(1):211-5. doi: 10.1097/scs.0b013e31814fb80e.

PMID:
18216691
13.

Comparative bioavailability study of two phenoxymethylpenicillin potassium tablet formulations in healthy volunteers.

Moreno RA, Boldrina L, Guermani A, Mazucheli J, Sverdloff C, Borges NC.

Int J Clin Pharmacol Ther. 2007 Dec;45(12):669-76.

PMID:
18184536
14.

[Comparison study of two glimepiride formulations bioavailability in healthy volunteers of both sexes after a single dose administration].

Borges NC, Taveira Ydel A, Mazucheli JA, Haddad AL, Astigarraga RE, Moreno RA.

Arq Bras Endocrinol Metabol. 2007 Aug;51(6):950-5. Portuguese.

PMID:
17934662
15.

Digoxin bioequivalence study: determination in human plasma by microparticle enzyme immunoassay.

Borges NC, Guermani A, Mazucheli JA, Mendes GD, Moreno RA.

Int J Clin Pharmacol Ther. 2007 Jun;45(6):366-72.

PMID:
17595894
16.

Bootstrap confidence intervals for the mode of the hazard function.

Mazucheli J, Barros EA, Achcar JA.

Comput Methods Programs Biomed. 2005 Jul;79(1):39-47.

PMID:
15955591
17.

Correlation of Candida species and symptoms among patients with vulvovaginal candidiasis in Maringá, Paraná, Brazil.

Lopes Consolaro ME, Aline Albertoni T, Shizue Yoshida C, Mazucheli J, Peralta RM, Estivalet Svidzinski TI.

Rev Iberoam Micol. 2004 Dec;21(4):202-5.

Supplemental Content

Loading ...
Support Center